AHR and cancer: A common view of Trp-Kyn metabolism in cancer immunomodulation is that it promotes immune suppression through two main mechanisms: metabolic competition, where Trp depletion leads to T cell starvation, and the accumulation of Kyn, which acts as a ligand for the aryl hydrocarbon receptor (AhR) [67].